Late intensification with POMP chemotherapy prolongs survival in acute myelogenous leukemia--results of a Southwest Oncology Group study of rubidazone versus adriamycin for remission induction, prophylactic intrathecal therapy, late intensification, (Q43939447)
Jump to navigation
Jump to search
scientific article published on July 1, 1992
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Late intensification with POMP chemotherapy prolongs survival in acute myelogenous leukemia--results of a Southwest Oncology Group study of rubidazone versus adriamycin for remission induction, prophylactic intrathecal therapy, late intensification, |
scientific article published on July 1, 1992 |
Statements
Late intensification with POMP chemotherapy prolongs survival in acute myelogenous leukemia--results of a Southwest Oncology Group study of rubidazone versus adriamycin for remission induction, prophylactic intrathecal therapy, late intensification, and levamisole maintenance (English)
F. S. Morrison
K. J. Kopecky
D. R. Head
J. W. Athens
S. P. Balcerzak
C. Gumbart
L. Dabich
J. J. Costanzi
C. A. Coltman